Kobayashi Pharmaceutical Co., Ltd.
Climate Impact & Sustainability Data (2020, 2021, 2022)
Reporting Period: 2020
Environmental Metrics
ESG Focus Areas
- Environmental
- Social
- Governance
Environmental Achievements
- Reduced CO2 emissions by 24% per unit of sales vs. fiscal 2005/3
- Achieved medium-term targets for recycling at all factories in 2020
- 99.8% recycling rate
Social Achievements
- Launched and established portfolio of products with eco labeling
- Implemented work-style reforms
- Continued to use Diversity Index
Governance Achievements
- Established a dedicated ESG department
- Enhanced discussions on medium-term management plan, sustainability, risks, and capital productivity
- Board of Directors reforms
Climate Goals & Targets
- Consolidated net sales of ¥280 billion, of which ¥90 billion will originate from markets outside of Japan by 2030
- Achieve a four-year contribution rate of new products of 20% or more
- 54.6% reduction in Group’s total CO2 emissions from 2017 levels by 2030
- Double production per worker by 2030
- Establish four new products in the market each year
Environmental Challenges
- Lower utilization rates caused by the COVID-19 pandemic worsened emissions per unit of sales.
- Weaker inbound tourism demand and economic stagnation caused by COVID-19.
- Risks of greenhouse gas-related regulations, reduced demand for some product sectors, and dramatic increases in the price of raw materials.
Mitigation Strategies
- Energy-saving measures in our offices and manufacturing upgrades.
- Developed products after confirming whether raw materials can be used in China, and whether these products can be used in China’s living environment.
- Took appropriate measures to address each risk and opportunity identified through climate change scenario analysis.
Supply Chain Management
Supplier Audits: Survey of 40 major suppliers of raw materials to assess the risk of human rights violations in 2020
Responsible Procurement
- Kobayashi Pharmaceutical Basic Procurement Policy
- Policies on strengthening respect for human rights and fulfilling our corporate social responsibilities
Climate-Related Risks & Opportunities
Physical Risks
- Reduced sales of strongly seasonal products due to unseasonable weather
Transition Risks
- Burden imposed by carbon tax due to the trend towards reducing greenhouse gases
Opportunities
- Increased yields of natural raw materials and greater demand for products to help deal with heat
Reporting Standards
Frameworks Used: International Integrated Reporting Framework, Guidance for Collaborative Value Creation
Certifications: Null
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Products with eco labeling
- Products using recycled and biomass plastics
Awards & Recognition
- Not disclosed
Reporting Period: 2021
Environmental Metrics
ESG Focus Areas
- Environmental
- Social
- Governance
Environmental Achievements
- Transitioned Sendai Kobayashi Pharmaceutical to zero CO2 emission electricity in 2020
- Switched to environmentally friendly resins with a low impact on the environment, such as recycled and biomass plastic, starting with top-selling brands Shoshugen and Liquid Bluelet products
Social Achievements
- Introduced a system allowing side jobs along with liberalization of the dress code in February 2022
- Held a panel discussion featuring three general managers, entitled “What is diversity promotion?” and converted the content of the discussion into a video
- Held training for female leaders
Governance Achievements
- Increased the number of outside directors and created new committees with the aim of improving our governance
- Established a Nomination Committee and Compensation Advisory Committee
- Established an Advisory Board
Climate Goals & Targets
- Attain consolidated net sales of ¥280 billion in 2030, with ¥90 billion of that amount originating in markets outside of Japan
- Reduced total CO2 emissions of the Group (Scope 1 and 2) by 51% and of entire supply chain (Scope 3) by 15% compared to 2018 by 2030
- Raise the percentage of management positions held by women to 16% or higher in 2022
Environmental Challenges
- Loss of inbound demand due to the spread of the novel coronavirus
- Reduced production in 2020
- Increased use of water to prevent snow melting and freezing at some plants
- Increased production of products that require a lot of water
- Decreased needs for annual paid holidays owing to the COVID-19 pandemic
- Limited in-store floor space presents a challenge for OTC sales channels
- High percentage of products susceptible to seasonality
Mitigation Strategies
- Used water flow meters to control water consumption and reused water from water purification systems
- Maintained a high recycling rate of 99.9%
- Improving flexible work programs
- Boosting investment in advertising, focusing on strong international businesses
- Increased investment in research and development
- Deploying unmanned and automated equipment
- Strengthening profits at each business, and improving capital efficiency through dividend increases and share buybacks
- Leveraging e-commerce for niche products
- Integrating the Direct Marketing Division and Healthcare Division to strengthen domestic e-commerce and online business strategy
- Adopting in-house eco standards to further advance efforts to lower the environmental impact of products and operations
Supply Chain Management
Supplier Audits: Survey of 40 major suppliers of raw materials in 2020 and 62 primary (Tier 1) suppliers of raw materials, and 367 secondary (Tier 2) suppliers in 2021
Responsible Procurement
- Kobayashi Pharmaceutical Basic Procurement Policy
Climate-Related Risks & Opportunities
Physical Risks
- Increased frequency of flood damage
- Increased water use
- Changes in areas where body warmers are sold/market shrinking
- Cost of relocating factories from low-lying areas
- Halting of procurement due to extinction
Transition Risks
- Introduction of carbon tax
- Carbon credit purchase cost
- Changes in demand
Opportunities
- Cost reduction through energy conservation
- Stable supply due to increased yields
- Price reductions due to increased yields
- Creation of new markets due to ethical orientation
- Increased sales of products to counter heatstroke
- Sale of emission credits
Reporting Standards
Frameworks Used: International Integrated Reporting Framework, Guidance for Collaborative Value Creation
UN Sustainable Development Goals
- Leave no one behind
Meeting needs that are too small for mass market business
Sustainable Products & Innovation
- Products with packaging that meets our eco standards are presented with “ECO” labels
Awards & Recognition
- Intellectual Property Achievement Award from the Commission of the Japan Patent Office
Reporting Period: 2022
Environmental Metrics
ESG Focus Areas
- Environment
- Social
- Governance
Environmental Achievements
- Achieved Scope 3 target for CO2 emissions reduction
- Acquired SBTi validation for GHG emissions reduction targets
- Introduced ecological standards into new product development in 2021
- Switched to highly sustainable materials for plastic packaging
- Used 100% sustainable paper packaging
Social Achievements
- Launched a special pantyliner for discharge, becoming the first company in Japan to do so
- Implemented job rotation and training to promote the advancement of women
- Improved employee job satisfaction and percentage of employees feeling able to work in mentally and physically good condition (based on employee attitude surveys)
Governance Achievements
- Clarified its attitude and commitment to actively investing in human resources in the form of a promise to its employees
- Established a five-in-one development system combining R&D, technology development, development planning, brand management, and Central R&D Laboratory support to strengthen competitiveness of existing products
- Reorganized three departments (Finance and Accounting, Public Relations and IR, and Business Support) under the direct control of the president to increase the speed of decision-making
Climate Goals & Targets
- Become “Kobayashi Pharmaceutical, perfect for digital manufacturing work” by 2030
- Lower GHG emissions by 51% for Scopes 1 and 2, and by 15% for Scope 3 by 2030 (compared to 2018)
- Create new businesses worth ¥8.0 billion in net sales in FY2030
- Achieve ¥90 billion in net sales in the International Business by 2030
- Raise the percentage of management positions held by women to 16% or higher by 2025
- Maintain the four-year contribution rate of new products at 13% or higher
- Launch two new digital products in the femtech field within three years
Environmental Challenges
- Sluggish sales growth of existing products in the domestic market
- Decreasing number of new product launches
- High raw material and utility costs
- Product supply issues due to supply chain disruptions
- Discrepancy between the Company’s purpose and promises to its employees and its current work methods and corporate culture
Mitigation Strategies
- Accelerating product development by establishing concurrent, unique themes
- Strengthening marketing promotions focused on e-commerce
- Working to build a stable supply system for pharmaceutical products
- Implementing a Company-wide plan to put the theme of the medium-term management plan, “I make a wish and I make it happen,” into practice
- Implementing dialogue training for managers and obtaining psychological safety facilitator qualifications for executives
Supply Chain Management
Responsible Procurement
- CSR procurement
- Procuring low-carbon raw materials and switching to low-carbon specifications
- Making procurement locations and raw materials more diverse
Climate-Related Risks & Opportunities
Physical Risks
- Uncertainty around raw material supply due to natural disasters
- Decrease in sales of body warmers due to global warming
- Increase in price of naturally derived materials
Transition Risks
- Increased cost of container and packaging recycling
- Avoidance of high-carbon products
- Taxation on Scope 1 and 2 emissions due to carbon tax introduction
- Taxation on Scope 3 emissions due to carbon tax introduction
- Increase in price of environmentally friendly resins
- Increase in price of renewable energy
- Transition to environmentally friendly products made by other companies
Opportunities
- Development of new products to meet the needs from fewer people going out and of the e-commerce market
- Provide and strengthen exclusive e-commerce products
- Develop antiperspirants, heatstroke prevention products, and infectious disease prevention products
Reporting Standards
Frameworks Used: International Integrated Reporting Framework, Guidance for Collaborative Value Creation
Certifications: SBTi certification for 1.5°C level GHG emissions reduction targets
Sustainable Products & Innovation
- Shoshugen SAVON (refillable air freshener)
- Eyebon eye wash (bottle made with biomass raw materials)